Antihypertensive drug-associated adverse events in osteoarthritis: a study of a large real-world sample based on the FAERS database
ARBs, especially valsartan, have significant positive signals for OA AEs. Therefore, ARB drugs, especially valsartan, should be used with caution when treating patients with OA combined with hypertension.
Authors
- Jingkai Di (ORCID: https://orcid.org/0000-0002-2814-9400)
- Xingjia Mao
- Zijian Guo (ORCID: https://orcid.org/0000-0003-4986-9308)
- Suming Chen (ORCID: https://orcid.org/0000-0002-8017-0282)
- Chuan Xiang (ORCID: https://orcid.org/0000-0002-1121-6443)
- Changxin Xiang
- Zhibo Zhang (ORCID: https://orcid.org/0000-0001-8534-7190)
- Zehui Yan
- Zehua Wang (ORCID: https://orcid.org/0009-0007-2803-9942)
- Xiaoke Li
- Changjiang Mu
- Zui Tian
Institutions
- Shanxi Medical University (CN)
- Sir Run Run Shaw Hospital (CN)
- Second Hospital of Shanxi Medical University (CN)
- Zhejiang University (CN)
- Taiyuan University of Technology (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2024-09-02
- DOI
- https://doi.org/10.3389/fphar.2024.1404427
- Citations
- 3
- Primary Topic
- Inflammatory mediators and NSAID effects
- Type
- article
- Field-Weighted Citation Impact
- 1.34